Stock Updates

Today’s Top Gainers in the Market Amgen Inc. (NASDAQ:AMGN) from Healthcare

Today’s top gainers include the company Amgen Inc. (NASDAQ:AMGN) which is in the industry Biotechnology, gaining -0.25% today. In the last week its performance is 5.14%, and -1.62% for the past quarter. Currently, Amgen Inc., AMGN has a target price of 183.88, so today’s gain of -0.25% is a significant step towards its target price. The GAP today is therefore -0.12%.

Amgen Inc. (NASDAQ:AMGN), has a market cap of 117505.65, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 81.30%.

At the current price of 155.66, it has a dividend yield of 2.56%, and its target price is 183.88. This is with a profit margin of 32.60%, and total debt/equity of 1.2. Amgen Inc. (NASDAQ:AMGN) has a P/E of 16.51, as well as a forward P/E of 12.82.

With a current EPS of 9.45, and a forecasted EPS growth for next year at 8.91%,Amgen Inc. (NASDAQ:AMGN) has had a EPS growth for the past five years at 13.60%. For the next five years EPS growth is projected to be 8.37%.

Performance for the year is 2.78%. Since its IPO date on 09/07/1984, the total performance to date is -2.56%.

Volume today for Amgen Inc. (NASDAQ:AMGN), is 912429, while its average volume is 2839.14. Whilst the total gain today was -0.25%, it did have a day high of -4.41%.

Volatility for this week has been at 1.70%, and 1.69% for the month. The 52-week low for Amgen Inc., AMGN has been 21.89%, while the 52-week-high has reached -12.38%.

Looking at its return of investments, which is 12.50%, and its return on assets is 10.00%. Amgen Inc. (NASDAQ:AMGN) has an operating margin of 39.90%. With a sales growth of 9.80% quarter over quarter. Bearing in mind that Amgen Inc., AMGN is in the sector Healthcare, its long-term debt/equity is 1.12, and has a current ratio of 5 and 4.7 for quick ratio.

So what is the value of Amgen Inc.? Well its PEG is 1.97, and the P/S is 5.3, along with a P/B of 4.1. Meanwhile it has a p/cash of 3.38.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment